Prevention of immune dysfunction and vitamin E loss by dehydroepiandrosterone and melatonin supplementation during murine retrovirus infection

Immunology

Volumn 96, Issue 2, 1999, Pages 291-297

  Zhang, Z ^a   Araghi Niknam, M ^a   Liang, B ^a   Inserra, P ^a   Ardestani, S K ^a   Jiang, S ^a   Chow, S ^a   Watson, R R ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; IMMUNOMODULATING AGENT; MELATONIN; PRASTERONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALPHA TOCOPHEROL DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; HELPER CELL; HORMONAL THERAPY; LIPID PEROXIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS INFECTION;

ANIMALS; ANTIOXIDANTS; B-LYMPHOCYTES; CELL DIVISION; CHOLESTEROL; CYTOKINES; DEHYDROEPIANDROSTERONE; DRUG THERAPY, COMBINATION; FEMALE; LIPID PEROXIDATION; LIVER; MELATONIN; MICE; MICE, INBRED C57BL; MURINE ACQUIRED IMMUNODEFICIENCY SYNDROME; PHOSPHOLIPIDS; RETROVIRIDAE INFECTIONS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS; VITAMIN E;

EID: 0032923093     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00628.x     Document Type: Article

References (45)

1. 1. LIANG B., WANG J.Y. & WATSON R.R. (1996a) Murine AIDS, a key to understanding retrovirus-induced immunodeficiecy. Viral Immunol 98, 225.
2. 2. CLERICI M., HAKIM F.T., VENZON D.J. et al. (1993) Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 9, 759.
3. 3. BRADLEY W.G., OGATA N., GOOD R.A. & DAY N.K. (1993) Alteration of in vivo cytokine gene expression in mice infected with a molecular clone the defective MAIDS virus. J AIDS 7, 1.
4. + subset regulation in viral infection. Preferential activation of Th2 cells during progression of retrovirus-induced immuno-deficiency in mice. J Immunol 148, 182.
5. 5. WANG Y., HUANG D.S., LIANG B. & WATSON R.R. (1994) Nutritional status and immune response in mice with murine AIDS are normalized by vitamin E supplementation. J Nutr 124, 2024.
6. 6. BRUAN D.P., KESSLER H., FALK I. et al. (1988) Monocytefunctional studies in asymptomatic human immunodeficiency disease virus (HIV) infected individuals. J Clin Immunol 8, 486.
7. 7. BARUCHEL, S. & WAINBERG M.A. (1992) The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus. J Leukoc Biol 52, 111.
8. 8. ABRAMS B., DUNCAN D. & HERTZ-PICCIOTTO I. (1993) A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men. J AIDS 6, 949.
9. 9. JACOBSON M.A., FLUSARO R.E., GALMARRINI M. & LANG W. (1991) Decreased serum dehydroepiandrosterone is not associated with an increased CD4 cell count of 200. J Infect Dis 164, 864.
10. 10. ARAGHI-NIKAM M., ZHANG Z., INSERRA P. & WATSON R.R. (1997) Cytokine dysregulation and increased oxidation is prevented by dehydroepiandrosterone in mice infected with murine leukemia retrovirus. Proc Soc Exp Bio Med 216, 386.
11. 11. SUZUKI T., SUZUKI N., DAYNES R.A. & ENGLEMAN E.G. (1991) Dehydroepiandrosterone enhances of IL-2 production and cytotoxic effector function of human T-cells. Clin Immunol Immunopathol 61, 202.
12. 12. ARAGNO M., TAMAGNO E., BOCCUZZI G. et al. (1993) Dehydroepiandrosterone pretreatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride. Biochem Pharm 46, 1689.
13. 13. ZHANG Z., INSERRA P., LIANG B. & WATSON R.R. (1997) Melatonin, immune modulation, and aging. Autoimmunity 26, 43.
14. 14. PIERI C., MARRA M., MORONI F., RECCHIONI R. & MARCHESELLI F. (1994) Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 55, 271.
15. 15. MOCCEGIANI E., BULIAN D., SANATARELLI L. et al. (1994) The immuno-reconstituting effect of melatonin or pineal grafting and its relation to zinc pool in aging mice. J Neuroimmunol 53, 189.
16. 16. LIANG B., ARDESTANI S., MARCHALONIS J.J. & WATSON R.R. (1996b) T-cell-receptor dose and the time of treatment during murine retrovirus infection for maintenance of immune function. Immunology 87, 198.
17. 17. WANG Y., HUANG D.S., WOOD S. & WATSON R.R. (1995) Modulation of immune function and cytokine production by various levels of vitamin E supplementation during murine AIDS. Immunopharmacology 29, 225.
18. + T cells from young and aged mice. J Jmmunol 145, 1295.
19. 19. BURTON G.W., WEBB A. & INGOLD K.U. (1985) A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratios. Lipids 20, 29.
20. 20. IVERSON S.A., CAWOOD P., MADIGAN M.J., LAWSON A.M. & DORMANDY T.L. (1984) Identification of a diene conjugated component of human lipid as octadeca-9, 11 dienoic acid. FASEBS Lett 141, 320.
21. 21. RAHEJA R.K., KAUR C., SINGH A. & BHATIA I.S. (1973) New colorimetric method for the quantitative estimation of phospholipids without acid digestion. J Lipid Res 14, 695.
22. 22. ZAK B. (1965) Total and free cholesterol. In: Standard Methods of Clinical Chemistry (ed. S. Meites), Vol 5, p. 79. Academic press, New York, NY.
23. 23. HENDERSON E.E., YANG J.Y. & SCHWARTZ A. (1992) Dehydroepiandrosterone and synthetic DHEA analogs are modest inhibitors of HIV-1 IIIB replications. AIDS Res Hum Retroviruses 6, 459.
24. 24. URSINI M.V., LETTIERI T., BRADDOCK M. & MARTINI G. (1993) Enhanced activity of human G6PD promoter transfected in Hela cell producing high levels of HIV-1 Tat. Virology 196, 338.
25. 25. WISNIEWSKI T.L., HILTON C.W., MORSE E.V. & FRANK S. (1993) The relationship of serum DHEA-S and cortisol levels to measures of immune function in human immunodeficiency virus-related illness. Am J Med Sci 305, 79.
26. 26. MULDER J.W., JOS FRISSEN P.H., KRIJNEN P. et al. (1992) Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men. J Infect Dis 165, 413.
27. 27. WATSON R.R., CHUNG S., HULS A. & ARAGHINIKNAM M. (1996) Dehydroepiandrosterone (DHEA) and diseases of aging. Drugs Aging 9, 274.
28. 28. REGELSON W., LORIA R. & KALIMI M. (1994) Dehydroepiandrosterone (DHEA) the 'mother steroid': I. immunologic action. Ann N Y Acad Sci 719, 553.
29. 29. OKABE T., HAJI M., TAKAYANAGI R. et al. (1995) Up-regulation of high-affinity dehydroepiandrosterone binding activity by dehydroepiandrosterone in activated human T lymphocytes. Clin Endocrinol Metab 80, 2993.
30. 30. MEIKLE A.W., DORCHUCK R.W., ARANEO B.A. et al. (1992) The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T-cells. J Steroid Biochem Mol Biol 42, 293.
31. 31. KIM H.R., RYU S.Y., KIM H.S. et al. (1995) Administration of dehydroepiandrosterone reverses the immune suppression induced by high dose antigen in mice. Immunol Invest 24, 583.
32. 32. HENGNER D. & PLATT D. (1975) Effect of essential phospholipid on the properties of ATPase of isolated rat liver plasma membrane of young and old animals. Mech Ageing Dev 4, 191.
33. 33. MAESTRONI G.I. (1995) T-helper-2 lymphocytes as peripheral target of melatonin signaling. J Pineal Res 18, 84.
34. 34. CALVO J.R., RAFII-EL-IDRISSI M., POZO D. & GUERRERO J.M. (1995) Immunomodulatory role of melatonin: specific binding sites in human and rodent lymphoid cells. J Pineal Res 18, 119.
35. +). FASEB J 9, 1331.
36. + cells. J Immunol 159, 574.
37. 37. GUERRERO J.M. & REITER R.J. (1992) A brief survey of pineal gland-immune system interrelationships. Endocrinol Res 18, 91.
38. 38. LIANG B., MARCHALONIS J.J. & WATSON R.R. (1997) Prevention of immune dysfunction and loss of Cryptosporidium resistance during murine retrovirus infection by T cell receptor peptide immunization. Nutr Res 17, 677.
39. 39. GREENSPAN H.C. & AROUMA O. (1994) Oxidative stress and apoptosis in HIV infection: a role for plant-derived metabolites with synergistic antioxidant activity. Immunol Today 15, 209.
40. 40. ALLARD J.P., AGHDASSI E., CHAU, J., SALIT I. & WALMSLEY S. (1998) Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 67, 143.
41. 41. SPENCER N.F., POYNTER M.E., HENNEBOLD J.D., EHLER L.A. & FAUCI A.S. (1995) Does DHEAS restore immune competence in aged animals through its capacity to function as a natural modulator of peroxisomeactivities? Ann N Y Acad Sci 774, 200.
42. + T cells using a combination of cytokines. J Exp Med 188, 83.
43. 43. GALLICHIO V.S., TSE K.F., MORROW J. & HUGHES N.K. (1996) Suppression of haemotopocitic support function is associated with overexpression of IL-4 and transforming growth factor-β1 in LP-BMS murine leukaemia virus-infected stromal cell lines. Acta Haematol 95, 204.
44. 44. COHEN O.J., KINTER A. & FAUCI A.S. (1997) Host factors in the pathogenesis of HIV disease. Immunol Rev 159, 31.
45. 45. POLI G., BRESSLER P., KINTER A. et al. (1990) Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 172, 151.